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1. Introduction
Due to the increase of aged patients with atherosclerosis, more attention should be paid to
the endothelial damage of great vessels. The damaged endothelium is more susceptible to
bacterial infections. The reports or papers of infected aneurysms (mycotic aneurysms) are
increasing in Pubmed search (Figure 1), which is consistent with personal experience in dai‐
ly practice. The reasons for the increase were due to several causes: 1) the increase of aged
patients with more risk of atherosclerosis than before, 2) an improvement of CT imaging
and MR imaging, 3) more awareness of the disease. We focused the diagnosis and manage‐
ments of infected aneurysms, and the diseases needed to differentiate from infected aneur‐
ysms, such as collagen vascular diseases and periaortitis.
1.1. Diagnosis of infected aneurysms
Risk factors for infected aneurysm include: 1) Endothelial damage caused by atherosclerosis
including pre-existing aneurysm [1], 2) Antecedent infection including bacteremia, 3) Arteri‐
al injury including iatrogenic mechanisms, such as percutaneous coronary intervention [2].
When the intima is diseased, bacteria can pass through it into deep layers of the aorta and
can establish infection. Infective endocarditis (IE) remains to be main cause of infected
aneurysm [3], because the risk factors of IE are very similar to those of infected aneurysms,
and bacteremia and septic emboli from heart are often common features of IE.
Staphylococcus species (spp) and Salmonella spp are two major bacteria causing infected
aneurysm, 28 to 71 percent and 15 to 24 percent of causes, respectively [4,5]. Streptococ‐
cus  pneumoniae  may be  the  third  major,  re-emerging,  cause  of  infected aneurysms [6].
The pathology of the diseased site includes acute or chronic inflammation with bacterial
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infection, abscesses, and necrosis. The suprarenal abdominal aorta is most commonly in‐
volved site.
Figure 1. Results of Pubmed search using mycotic aneurysm or infected aneurysm.
Symptoms of an infected aneurysm vary according the lesion diseased. For example, ab‐
dominal pain and diarrhea is observed if abdominal aorta is involved, painful pulsatile mass
if superficial artery is involved, and chest pain if thoracic aorta is involved. An infected
aneurysm involving deep arteries or aorta may cause only fever. It might be followed as fe‐
ver of unknown origin, and could be diagnosed as an infected aneurysm only after CT imag‐
ing is acquired. If the patients were with bacteremia or a persistent high fever and their
etiology was not determined, the contrast-enhanced CT imaging would be the choice for
searching the diseased lesion, and an asymptomatic infected aneurysm would be one of dif‐
ferential diagnoses.
The next step of diagnosing an infected aneurysm is based on blood cultures and imaging.
In all suspicious patients, blood cultures should be examined. About 50-85% of patients may
be positive [5,7]. If negative, however, the infected aneurysm cannot be ruled out. Contrast-
enhanced CT imaging identified the infected aneurysm. Findings on CT angiography of an
infected aneurysm include a disruption of aortic wall calcification, soft tissue inflammation
or mass around a vessel, and periaortic fluid or air collection [8,9]. These findings can differ‐
entiate from other inflammatory aortic disease. The wall of inflammatory aorta is thickened
and periaortic fibrosis sometimes observed in adhesion to surrounding organs. MR imaging
is another strong tools. The T2-weighted images or mixed T1/T2-weighted STIR images are
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able to visualize the edematous lesion. The diffusion images can detect fluid collection, and
gadolinium enhancement indicates the increase of inflammatory connective tissue.
In summary, the important things for the diagnosis of an infected aneurysm are the high
suspicion of this disease and obtaining blood cultures and enhanced CT or MR imaging.
1.2. Management of infected aneurysms
Surgical replacement or debridement is the treatment of choice combined with antibiotic
therapy [4]. The main aims of surgical procedures are removal of infected tissue and re‐
vascularization if  distal  perfusion is  limited.  Mortality rate without surgery was 85 per‐
cent  with  infected  thoracic  aneurysm  and  96  percent  with  infected  aortic  aneurysm
[10,11].  Figure  2  shows  a  gradually  enlarged  infective  aneurysm  treated  on  medication
alone  despite  the  control  of  bacteremia  [12].  Among  patients  who  underwent  surgery,
mortality  rates  were the highest  for  patients  with infected arch aneurysms (50 %)  com‐
pared with supra-renal aortic aneurysms (43%), distal descending thoracic aneurysms (33
%),  proximal  descending  thoracic  aneurysms  (16  %),  or  infra-renal  aortic  aneurysms  (4
%) [10,13].  Endovascular  stenting is  reported to be effective in some systematic  reviews
with  low mortality  [14,15].  Because  the  infected  focus  is  not  removed by  endovascular
stenting,  the  procedures  may  be  palliative,  and  more  persistent  or  recurrent  infections
are likely to occur compared to surgical  procedures.  However,  endovascular procedures
could be a secondary choice for patients who refuse surgery, those with a very high risk
for surgery, and those with a ruptured infected aneurysm.
The initial choice of antibiotic therapy should be based on the culture and susceptibility
results.  Until  the  results  become available,  the  combination  treatment  with  vancomycin
and  a  ceftriaxone,  a  fluoroquinolone,  or  piperacillin-tazobactam  is  preferable  targeting
gram-negative Salmonella  and enteric  bacteria.  The optimal  duration of  antibiotic  thera‐
py is  uncertain  because of  the  lack of  randomized clinical  trials.  In  general,  four  to  six
weeks  of  parenteral  antimicrobial  therapy  is  performed  for  the  treatment  of  infected
aneurysm followed by  principles  of  vascular  graft  infection  or  infective  endocarditis  of
prosthesis  valve.  A  longer  duration  of  treatment  or  additional  oral  antibiotics  may  be
warranted in the clinical  course of  persist  elevation of  C-reactive proteins or  recurrence
of fever when drug-related fever is excluded.
In summary, the surgical replacement in combination with antibiotics is the treatment of
choice, and endovascular procedures may be palliative. The management is followed by
principles of vascular graft infection or infective endocarditis of prosthesis valve.
2. Inflammation of aorta: “Aortits”
Large  vessel  vasculitits  such  as  Takayasu's  arteritis  and  giant  cell  arteritis,  rheumatic
and HLA-B27–associated spondyloarthropathies,  Behçet's  syndrome,  and infections  such
as syphilis, tuberculosis may be the cause of inflammation of aorta, and we must differ‐
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entiate  these  from infected aneurysms when blood culture  is  negative  or  infected focus
remains  unclear.  Another  disease  which  we  must  differentiate  is  IgG4-related  diseases
(chronic periaortits).
Figure 2. A case of medical treatment of an infected aneurysm. A 75-year-old man with familial hypercholesterolemia,
cerebral infarction, and coronary bypass grafting presented with high fever and chest pain. Panel A and B showed a
severely calcified ascending aorta. The repeated CE-CT on the 5th day revealed aneurysmal change with protrusion
(Panel C), indicating an infected aneurysm. Due to a prohibitive risk of surgery, medical treatment was the choice of
him and his family, but the infected aneurysm gradually enlarged despite the control of bacteremia with antibiotics
(13th day: Panel D, 24th day: Panel E, and 58th day; Panel F), and he died 2 months after onset.
A detailed history and a careful physical examination are important for the diagnosis and
assessment of the extent of vascular lesions. The mean age at onset of Takayasu's arteritis
and giant cell arteritis was between 17 and 26 years of age and with 69 years, respectively,
primarily in women (about 80 %) [16]. Systemic symptoms are common such as fatigue,
weight loss, and low-grade fever are common in these disorders, along with local symp‐
toms, for example, arthralgia, skin lesion (erythema nodosum), and abdominal pains. HLA-
B27–associated spondyloarthropathies accompanies with ankylosing spondylitis, reactive
arthritis, or inflammatory bowel disease with negative rheumatic factors. Skin and mucosa,
ocular system, GI manifestations include abdominal pain, nausea, and diarrhea with or
without blood, and/or musculoskeletal and neurological system are involved in Behçet's
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syndrome. Allergic features such as atopy, asthma, and modest peripheral eosinophilia,
along with tumorous swelling in many organs and elevated serum IgG4 levels above the up‐
per limit of normal(>135 mg/dL) are the characteristics of IgG-4 related diseases [17].
3. Takayasu's arteritis, giant cell arteritis
Takayasu's arteritis, also called pulseless disease, involves the ascending aorta and aortic
arch, and carotid and subclavian arteries, causing dilations and obstruction at the stage of
healing and recurrences. CT angiography revealed the diseased lesion, thickened arterial
wall in acute phase and aneurysmal or stenotic lesion in chronic phase [18]. The ultrasonog‐
raphy and MR angiography are also useful. In acute phase, the high signal of T2-weighted
and/or STIR MR images and the increased uptake of 18Fluorodeoxy-glucose indicate the
presence of active inflammation [19]. The mainstay of therapy for Takayasu's arteritis is glu‐
cocorticoids. Giant cell arteritis (GCA) is a chronic vasculitis of large and medium sized ves‐
sels. The following classification criteria were as follows: 1) Age older than 50 years at onset,
2) Localized headache de novo, 3) Tenderness or decreased pulse of the temporal artery, 4)
Erythrocyte sedimentation rate (ESR) greater than 50 mm/h, 5) Biopsy-proven necrotizing
arteritis with multinucleated giant cells [20].
4. IgG4-related diseases: Chronic periaortits
IgG4 -related disease is a newly recognized syndrome of unknown etiology characterized by
fibroinflammatory condition, in which tumefactive lesions, a dense lymphoplasmacytic in‐
filtrate rich in IgG4-positive plasma cells. Various symptoms are observed according to the
lesions involved, although patients feel well at the time of diagnosis without fever. Seventy
percent of patients have elevated serum IgG4 concentrations [17]. CT imaging features of ar‐
terial lesions are characterized by homogeneous wall thickening and enhancement in the
late phases after contrast infusion accompanying the increase of connective tissue indicating
sclerosing inflammation [21]. This indicates chronic periaortitis, which resembles the infect‐
ed aneurysm with periaortic abscess (Figure 3). Therefore, the diseases should be differenti‐
ated from infected aneurysm by not only the imaging features but also clinical symptoms or
negative blood cultures. Glucocorticoids typically the first line of therapy.
5. Conclusions
Due to the increase of aged patients with atherosclerosis, more attention should be paid to
the endothelial damage of great vessels and an infected aneurysm should be properly diag‐
nosed and carefully managed.
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Figure  3.  A  case  of  chronic  periaortitis  with  retroperitoneal  fibrosis.  A  75-year-old  man  presented  with  vague
discomfort  of  lower  abdomen.  Panel  A  was  at  presentation.  Two  months  later  the  symptoms  remained  un‐
changed  with  8.5mg/dL  of  C-reactive  protein  but  without  fever.  Repeated  CT  was  performed  (Panel  B).  Biopsy
of  the  tissue revealed the  infiltration of  inflammatory  cells  and no bacteria  (Panel  C).  Panel  D  was  three  weeks
after the glucocorticoid therapy.
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